Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SOS1 inhibitors(Son of sevenless homolog 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | Preclinical | South Korea | 30 Apr 2025 | |
Breast Cancer | Preclinical | South Korea | 30 Apr 2025 | |
Chronic Myelogenous Leukemia | Preclinical | South Korea | 30 Apr 2025 | |
Colonic Cancer | Preclinical | South Korea | 30 Apr 2025 | |
Non-Small Cell Lung Cancer | Preclinical | South Korea | 30 Apr 2025 | |
Stomach Cancer | Preclinical | South Korea | 30 Apr 2025 |